Caxton Associates (New York)’s Avient AVNT Stock Holding History

Caxton Associates (New York)’s Portfolio AVNT Stock Details AVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,574	Closed	-$1.53M	–	454
2022 Q3	$1.53M	Buy	+50,574	New	+$2.1M	0.2%	50
2019 Q2	–	Sell	-25,870	Closed	-$759K	–	398
2019 Q1	$759K	Buy	+25,870	New	+$812K	0.11%	96

Other funds holding AVNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marquard & Bahls Hamburg, Germany $677M AUM 9.39% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Caxton Associates (New York)'s AVNT Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Avient (AVNT) in Q4 2022, closing a stake of 50,574 shares — an estimated $1.53M sold.

Caxton Associates (New York) first reported a position in AVNT in Q1 2019 and held it in 2 quarters. The position peaked at $1.53M in Q3 2022. 261 funds tracked by Wall St. Rank hold AVNT as of Q4 2022.

Caxton Associates (New York) reported no remaining Avient position as of Q4 2022 after selling out during the quarter.
Caxton Associates (New York) sold 50,574 Avient shares in Q4 2022, an estimated $1.53M.
Caxton Associates (New York) first reported a position in Avient in Q1 2019 and held it in 2 quarters.
Caxton Associates (New York)'s Avient position peaked at $1.53M in Q3 2022.
261 funds tracked by Wall St. Rank held Avient as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.